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Abstract. Alcohol consumption has been recognized as a risk
factor for breast cancer. Experimental studies demonstrate
that alcohol exposure promotes the progression of existing
mammary tumors. However, the mechanisms underlying this
effect remain unclear. In the present study, the role of vascular
endothelial growth factor (VEGF) in alcohol promotion of
breast cancer development was investigated using a mouse
xenograft model of mammary tumors and a three‑dimensional
(3D) tumor/endothelial cell co‑culture system. For the mouse
xenograft model, mouse E0771 breast cancer cells were
implanted into the mammary fat pad of C57BL6 mice. These
mice were exposed to alcohol in their drinking water. For
the 3D co‑culture system, E0771 cells and MDA‑MB231
breast cancer cells were co‑cultured with SVEC4‑10EE2
and human umbilical vein endothelial cells, respectively. The
results demonstrated that alcohol increased tumor angiogenesis and accelerated tumor growth. Furthermore, it appeared
that alcohol induced VEGF expression in breast cancer cells
in vitro and in vivo. Blocking VEGF signaling by SU5416
inhibited tumor angiogenesis in the 3D tumor/endothelial cell
co‑culture system. Furthermore, injection of SU5416 into mice
inhibited alcohol‑promoted mammary tumor growth in vivo.
These results indicate that alcohol may promote mammary
tumor growth by stimulating VEGF‑dependent angiogenesis.
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Introduction
Breast cancer is the most common malignant tumor in females
worldwide and is the second leading cause of cancer‑related
mortality in the USA (1,2). There are multiple risk factors
for breast cancer, including genetic, reproductive/hormonal,
environmental and other lifestyle factors (3). Epidemiological
studies indicate that alcohol consumption increases the risk
of breast cancer in a dose‑dependent manner (4‑9). In addition, alcohol enhances the growth of existing breast tumors
and promotes metastasis (10‑12). However, the mechanisms
underlying these effects remain unclear.
Tumor growth and metastasis are dependent on angiogenesis. Vascular endothelial growth factor (VEGF) is one
of the most important known factors which stimulates vasculogenesis and angiogenesis. VEGF has an important role in
tumor angiogenesis via promoting proliferation, migration,
stabilization and survival of endothelial cells as well as tumor
cells (13,14). It has been demonstrated that the VEGF expression in breast cancer tissues is significantly higher than that in
the adjacent normal tissues (15). We previously demonstrated
that alcohol promoted angiogenesis and induced the expression of monocyte chemotactic protein‑1 (MCP‑1). However,
MCP‑1 only partially mediated the effect of alcohol, that is,
blocking MCP‑1 signaling only partially reversed the effect
of alcohol on angiogenesis and mammary tumor growth (16).
Alcohol‑induced tumor promotion may be mediated by
multiple factors and signaling pathways. Considering the
important role of VEGF in tumor angiogenesis and progression, we hypothesized that VEGF signaling is involved in
alcohol promotion of tumor angiogenesis and mammary
tumor growth. In the present study, we utilized in vitro and
in vivo model systems to address this hypothesis.
Materials and methods
Materials. Ethanol, fibrinogen, aprotinin and thrombin were
purchased from Sigma‑Aldrich (St. Louis, MO, USA), and
SU5416 was purchased from Calbiochem (San Diego, CA,
USA). Rat anti‑mouse CD31 monoclonal antibody was obtained
from BD Biosciences (San Diego, CA, US), while anti‑VEGF
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antibody was obtained from Santa Cruz Biotechnology, Inc.
(Dallas, TX, USA). Cytodex 3 beads were obtained from
Amersham Pharmacia Biotech Inc. (Piscataway, NJ, USA).
Cell culture. Mouse mammary adenocarcinoma cell line
(E0771) was provided by Dr. Enrico Mihich (Roswell Park
Cancer Institute, Buffalo, NY, USA) and maintained in
DMEM (Gibco‑BRL, Carlsbad, CA, USA) supplemented
with 10% fetal bovine serum (FBS; Hyclone, Logan,
UT, USA), penicillin (100 U/ml;), streptomycin (100
U/ml) and amphotericin B (0.25 mg/ml) at 37˚C with 5% CO2
(GBCBIO™ Technologies, Guangzhou, China). MDA‑MB231
breast cancer cells and SVEC4‑10EE2 murine endothelial
cells (both American Type Culture Collection, Manassas,
VA, USA) were grown in DMEM medium containing 10%
FBS and 100 U/ml penicillin and streptomycin at 37˚C with
5% CO2. Human umbilical vein endothelial cells (HUVECs;
American Type Culture Collection) were isolated from fresh
human placentas with type I collagenase (1 mg/ml) and grown
in Clonetics Endothelial Cell Growth Medium‑2 (EGM‑2;
Lonza, Walkersville, MD, USA). HUVECs were used between
passages 3 and 10.
Animals and alcohol exposure. Female C57BL/6 mice
(5‑6 weeks old) were purchased from the Experimental
Animal Center of Anhui Province (Hefei, China). All procedures were conducted according to the Guidelines of the
Animal Welfare Act approved by the Institutional Animal
Care and Use Committee of the Anhui Medical University
(Hefei, China). The mice were placed on a standard chow
diet and were allowed to acclimatize for one week prior to
starting the study. The paradigm of alcohol exposure has
been previously described (16). Briefly, mice were divided
into two groups and fed with standard chow ad libitum.
In the control group, the mice were provided with regular
drinking water (n=20). In the alcohol‑exposed group (n=18),
the mice received repeated cycles of chronic intermittent ethanol (2% v/v) exposure (12 h/day, 8:00pm‑8:00am)
for three weeks. The consumption of regular water or
alcohol‑containing water in the two groups was monitored
daily and no significant difference in the liquid intake
between the control and ethanol group was identified. The
average consumption of water or ethanol‑containing water
for each mouse was ~4 ml/day. The study was approved by
the ethics committee of Anhui Medical University.
Mouse tumor xenograft model. E0771 mouse breast cancer
cells are syngeneic to C57BL/6 mice. E0771 cells, implanted
subcutaneously in C57BL/6 mice, are immunosuppressive
and highly aggressive, invading locally into dermal layers
and the peritoneum as well as distantly to the lung, and have
characteristics which reflect the human disease (16,17). These
cells have been extensively used for mouse tumor xenograft
models. Briefly, three days following alcohol exposure, E0771
cells [2.5x105 in 100 µl phosphate‑buffered saline (PBS)]
were injected into the secondary mammary fat pad of mice
using a 23‑gauge needle. Following implantation, the mice
were continually provided normal drinking water or water
containing 2% ethanol. The tumor size was monitored every
three days. Two perpendicular dimensions of tumors were

measured using a dial caliper and the tumor volume was
calculated based on the formula: V=0.24a x b2 (a, the longest
dimension and b, the shortest dimension). Following implantation, 24 days later the mice were sacrificed and the tumors
were harvested for further detection (16).
To investigate the role of VEGF in alcohol‑induced
tumor promotion, an inhibitor of the VEGF receptor, Z‑3‑[(2,
4‑dimethylpyrrol‑5‑yl) methylidenyl]‑2‑indolinone (SU5416;
Sigma‑Aldrich) was injected into the mice. One day following
alcohol exposure, animals received intraperitoneal injection of
SU5416 [10 mg/kg in 100 µl, Su5416 was dissolved in ethanol and
diluted in 5% Tween‑80 (Amresco LLC, Solon, OH, USA) and
5% PEG‑400 (Shandong Lunan Chemical Technology Co., Ltd,
Tengzhou City, China) prior to injection] every three days. The
dosage has been previously demonstrated to effectively inhibit
VEGF signaling in mice (18). The tumor size was monitored
every three days.
Immunohistochemistry (IHC) and evaluation of average
microvessel density (AMVD). The procedure for immunohistochemical analysis was performed as described
previously (19). Tumor tissues were sectioned at the thickness
of 4 µm. The sections were incubated in methanol (0.3% H2O2)
for 30 min and treated with 0.1% Triton X‑100 (Amresco LLC)
for 10 min. The sections were washed with PBS three times
and blocked with 1% bovine serum albumin (BSA; Amresco
LLC) and 0.01% Triton X‑100 for 1 h at room temperature.
The sections were incubated with anti‑VEGF antibody (1:100)
or anti‑CD31 (1:50) antibody overnight at 4˚C. Negative
controls were performed by staining with isotype‑matched
IgG or PBS. Following rinsing in PBS, the sections were incubated with goat anti‑rat biotinylated monoclonal secondary
antibodies (Vector Laboratories Inc., Burlingame, CA, USA)
for 1 h at room temperature. The sections were washed three
times with PBS, then incubated in avidin‑biotin‑peroxidase
complex (1:100 in PBS; Vector Laboratories Inc., Burlingame,
CA, USA) for 1 h and developed in 0.05% 3,3'‑diaminobenzidine (Sigma‑Aldrich) containing 0.003% H2O2 in PBS. The
tumor microvessels that were visualized by CD31 IHC were
examined under a microscope (Olympus CX31; Olympus
Corporation, Tokyo, Japan). Ten random fields were quantified
and the AMVD was expressed as the number of microvessels/mm2 area.
Three‑dimensional (3D) endothelial tumor cell co‑culture
system. To investigate the effect of alcohol on tumor
angiogenesis, a 3D tumor/endothelial cell co‑culture was
performed as described previously (16,20). In this model,
endothelial cells were cultured on a fibrin gel bead system
alone or with tumor cells to form a 3D capillary tube‑like
network. Briefly, HUVECs or SVEC4 cells were trypsinized
and the cells (1x106) were mixed with cytodex beads (3x103)
in a 4 ml medium (EGM‑2 for HUVECs and DMEM for
SVECs). The mixtures were incubated at 5% CO2 at 37˚C
and gently shaken every 20 min for 4 h. Following this, 4 ml
of fresh medium was added to the tubes and the incubation
continued for another 4 h. The mixtures of cells/cytodex beads
were transferred to 25 ml tissue culture flasks and incubated
overnight to allow the bead‑non‑attached cells to adhere to
the flask. Following incubation, the mixtures of cells/cytodex
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Figure 1. Effect of alcohol exposure on VEGF expression and angiogenesis in mice. (A) E0771 mouse breast cancer cells were implanted in mammary fat pads
of C57BL6 mice. The mice were exposed to alcohol in drinking water for two weeks. Mice were sacrificed and mammary tumors were dissected and sectioned
for VEGF IHC as described in Materials and methods. (B) Tumor microvessels were identified by CD31 IHC and the AMVD was quantified and expressed as
the number of microvessels/mm2 area. The results are represented as the mean ± SEM of 20‑22 animals. *Denotes a statistically significant difference (P<0.05).
VEGF, vascular endothelial growth factor; IHC, immunohistochemistry; AMVD, average microvessel density.

beads were transferred to a 50 ml centrifuge tube and washed
three times with 20 ml of Ca 2+ ‑ and Mg2+ ‑free PBS. Then,
the beads with adherent cells were resuspended in medium
[2.5 mg/ml fibrinogen, 0.15 U/ml aprotinin (Amresco LLC),
pH 7.4]. Following this, 0.5 ml of the fibrinogen/bead suspension was added to 24‑well cell culture plates which were
pre‑coated with 0.625 U of thrombin (Sigma‑Aldrich). The
fibrinogen/bead solution was allowed to coagulate for 5 min
at room temperature and was then cultured in 5% CO2 at
37˚C for 20 min. The resulting fibrin gels contained endothelial cells (HUVECs or SVECs) adhering to the beads.
Then, 1 ml of medium (0.15 U/ml aprotinin) was added to
each well to equilibrate with the fibrin clot for 30 min at 37˚C
and 5% CO2. The medium was removed and replaced with
1 ml of fresh medium (0.15 U/ml aprotinin). For co‑culture of
endothelial cells/breast tumor cells, E0771 or MDA‑MB231
breast cancer cells (2x104 or 4x104, respectively) were layered
on top of the fibrin gels. The medium was changed every day.
In vitro alcohol exposure. A method utilizing sealed
containers was used to maintain alcohol concentrations in
the cell culture system (21). Briefly, the appropriate amount
of ethanol (using 95% ethanol stock) was added to the culture
medium to reach the desired concentration (0.2%). The cell
culture plates were placed in a sealed plastic container. In
each container, a water bath with 200 ml 0.2% ethanol was
deposited in order to maintain the ethanol concentration.
Prior to sealing each container, CO2 (60 ml) was injected.
The containers were placed in a humidified environment and
maintained at 37˚C with 5% CO2. With this method, ethanol
concentrations were maintained constantly over time in a cell
culture medium (21).
Immunoblotting. The immunoblotting was performed as
previously described (22). Briefly, aliquots of the protein
samples (30 µg) were separated on an SDS‑polyacrylamide
gel (Sigma‑Aldrich) and were transferred to nitrocellulose
membranes. The membranes were blocked with 5% BSA solution [pH 7.4, 0.05% Tween‑20 (Amresco LLC) in PBS] for 1 h
at room temperature. Anti‑VEGF antibody (1:500) was added
to the membranes (Millipore, Billerica, MA, USA) for 1 h at
room temperature. Membranes were probed with goat anti‑rat
monoclonal horseradish peroxidase‑conjugated secondary

antibody (Amersham Life Science, Arlington Heights, IL,
USA). The signals were detected by using the enhanced chemiluminescence method (Amersham Life Sciences) and were
exposed to X‑ray film for autoradiography. The membranes
were stripped with a stripping buffer for 15 min at room
temperature and immunoblotted with a rabbit anti‑mouse actin
monoclonal antibody (Santa Cruz Biotechnology, Inc.). The
images were scanned and the signal intensity was quantified
with Image J software (NIH, Bethesda, MD, USA).
VEGF enzyme‑linked immunosorbent assay (ELISA). ELISA
was performed in 100-µl volumes in triplicate using commercial kits for VEGF, according to the manufacturer's instructions
(R&D Systems, Minneapolis, MN, USA). The plates were
read at 450 nm on an ELx800 absorbance microplate reader
(Bio-Tek Instruments Inc., Winooski, VT, USA).
Statistical analysis. The data were analyzed using SPSS 17.0
software (SPSS, Inc., Chicago, IL, USA). All data are represented as the mean ± SEM. Differences among the treatment
groups were examined using analysis of variance. In the cases
where significant differences were detected, specific post‑hoc
comparisons between the treatment groups were examined
with Student‑Newman‑Keuls tests. In a number of the experiments, the results were analyzed by an unpaired Student's
t‑test. P<0.05 was considered to indicate a statistically significant difference.
Results
Ethanol induces VEGF expression and tumor angiogenesis.
The effect of alcohol on VEGF expression and tumor angiogenesis was investigated in a mouse xenograft model of mammary
tumors. As demonstrated in Fig. 1A, the VEGF immunoreactivity in the mammary tumor tissues of mice exposed to
alcohol was higher than that of the control mice. The AMVD
was also examined using CD31 (a marker of endothelial cells)
IHC. The quantification data are presented in Fig. 1B. Alcohol
consumption significantly increased the AMVD in mammary
tissues. To confirm alcohol stimulation of VEGF expression,
we examined the effect of alcohol on E0771 mouse breast
cancer cells in culture. Alcohol exposure upregulated VEGF
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Figure 2. Effect of alcohol on VEGF expression in E0771 cells. (A) E0771 cells were exposed to alcohol (0 or 0.2%) for the indicated times and cell lysates
were collected. The expression of VEGF was determined by western blotting as described in Materials and methods. The experiment was replicated three
times. (B) E0771 cells were exposed to alcohol (0 or 0.2%) for 12 or 24 h. The CM was collected for the analysis of VEGF by enzyme‑linked immunosorbent
assay. The experiment was replicated three times. *Denotes a statistically significant difference (P<0.05). VEGF, vascular endothelial growth factor; CM,
conditioned medium; EtOH, ethanol.
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Figure 3. Effect of alcohol on tumor angiogenesis in vitro. (A) The 3D tumor/endothelial cell co‑culture system was set up as described in Materials and
methods. Endothelial cells (SVECs or HUVECs) attached to cytodex beads were suspended in the fibrin gel containing SU5416 (0 or 2 µM) and breast cancer
cells (E0771 or MDA‑MB231) were placed on top of the gel. The endothelial cell sprouting was examined and recoded under a microscope following 12 h
in culture. The percentage of beads with endothelial sprouts was calculated. EC, SVECs or HUVECs; TC, E0771 or MDA‑MB231 cells. (B) SVEC/E0771
cell co‑culture with/without SU5416 (2 µM) was exposed to alcohol (0 or 0.2%) for 12 h. Following this, the percentage of beads with endothelial sprouts was
quantified. The experiment was replicated three times. (C) E0771 cells were maintained in a medium containing 1% FBS and exposed to alcohol (0 or 0.2%)
for 24 h. The CM was collected and SVECs were incubated with this CM for 12 h. Then, the percentage of beads with endothelial sprouts was calculated.
(D) The CM was collected from alcohol (0 or 0.2%)‑treated E0771 cells and SU5416 (0 or 2 µM) was added to the medium. SVECs were then incubated with
this conditioned medium for 12 h. The experiments were replicated three times. Each data point represents the mean ± SEM of three replicates.*P<0.05 and
**
P<0.01. 3D, 3‑dimensional; EC, endothelial cells; TC, tumor cells; CM, conditioned medium; EtOH, ethanol.

expression in E0771 cells (Fig. 2A) and increased the secretion
of VEGF to the culture medium (Fig. 2B).
Ethanol promotes tumor angiogenesis. We hypothesized that
alcohol increased VEGF production in breast cancer cells
and stimulated angiogenesis of endothelial cells. A previously
described 3D angiogenic model was utilized to test this hypothesis. With this system, we previously demonstrated that breast
cancer cells (E0771 cells or MDA‑MB231 cells) significantly
increased the vascular sprout formation of endothelial cells
(SVECs or HUVECs) (16). In the present study, VEGF signaling
in tumor/endothelial cell co‑culture was blocked using SU5416,
an inhibitor of VEGF receptor 2 (VEGFR2). As demonstrated in
Fig. 3A, inclusion of breast cancer cells (E0771 or MDA‑MB231)
in this 3D co‑culture system increased endothelial cell sprouting,

Figure 4. Effect of alcohol on mammary tumor growth in vivo. The implantation
of E0771 cells in C57Bl6 mice and alcohol exposure was performed as described
in Materials and methods. One day following E0771 cell implantation, mice
received an intraperitoneal injection of SU5416 (0 or 10 mg/kg) every three days.
The size of the mammary tumor was measured every three days as described in
Materials and methods (n=12 for each treatment group). EtOH, ethanol.
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which was indicative of enhanced angiogenesis. Treatment with
SU5416 completely blocked the promotion of angiogenesis
mediated by breast cancer cells. Alcohol exposure did not
increase endothelial cell sprouting when the endothelial cells
were cultured alone; however, it significantly increased endothelial cell sprouting in SVEC/E0771 co‑culture (Fig. 3B). More
importantly, SU5416 blocked alcohol‑stimulated angiogenesis
(Fig. 3B). To confirm the role of VEGF in alcohol‑stimulated
angiogenesis, the effect of conditioned medium collected from
alcohol‑treated E0771 cells on angiogenesis was examined.
As demonstrated in Fig. 3C, E0771 cell‑conditioned medium
significantly increased endothelial cell sprouting and alcohol
exposure further enhanced this effect. SU5416 completely
blocked alcohol‑stimulated angiogenesis. These results
suggested that alcohol‑enhanced tumor angiogenesis was mediated by VEGF signaling.
SU5416 inhibits ethanol‑promoted tumor growth in mouse
tumor xenograft model. A well‑established mouse xenograft
model of mammary tumors was utilized to validate the role of
VEGF in alcohol‑induced tumor promotion in vivo. As demonstrated in Fig. 4, alcohol consumption significantly promoted
the growth of mammary tumors in C57BL6 mice. Injection
of SU5416 inhibited alcohol‑stimulated tumor growth. These
results suggested that alcohol promotion of tumor growth may
be mediated by VEGF‑dependent angiogenesis.
Discussion
Alcohol consumption promotes the growth and metastasis of
breast cancer (10‑12). However, the mechanisms underlying this
effect remain unclear. VEGF has been implicated in tumor angiogenesis and progression. In the present study, it was demonstrated
that alcohol increases tumor angiogenesis and accelerates tumor
growth. Alcohol upregulates VEGF expression in breast cancer
cells in vitro and in vivo. Blocking VEGF signaling inhibits
alcohol‑stimulated tumor angiogenesis in a 3D tumor/endothelial
cell co‑culture system. Furthermore, blocking VEGF signaling
inhibited alcohol‑accelerated mammary tumor growth in mice.
These results suggest that VEGF‑dependent angiogenesis has an
important role in alcohol‑mediated tumor promotion.
Consistent with epidemiological evidence, alcohol
exposure promotes tumor progression and malignancy in
animals (16,23,24,25). In the present study, it was demonstrated that alcohol at a moderate concentration (2% in
drinking water during the dark cycle) enhances mammary
tumor growth in C57BL6 mice. Our previous results and
studies by others suggested that alcohol exposure may
enhance angiogenesis (16,23,26,27). The mechanisms underlying alcohol‑stimulated angiogenesis, however, are complex
and unclear. Alcohol may directly target endothelial cells,
or regulate the interaction between endothelial and tumor
cells. To the best of our knowledge, our previous study was
the first to demonstrate that alcohol promotes tumor/endothelial cell interaction and enhances tumor angiogenesis in a
3D co‑culture of tumor/endothelial cells (16). In this earlier
study, we demonstrated that alcohol stimulated MCP‑1
secretion from mammary tumor cells, which enhanced endothelial angiogenesis. However, blocking MCP‑1 signaling only
partially reversed the effect of alcohol on tumor angiogenesis.
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Therefore, we hypothesized that other factors are responsible
for mediating alcohol‑stimulated angiogenesis.
VEGF is one of the most potent effectors of physiological
and pathological angiogenesis, which has been proved to be
an important factor for tumor occurrence, progression and
metastasis of breast cancer (13). In the tumor microenvironment, VEGF is derived from various sources, including tumor
cells, inflammatory and stromal cells, platelets and vascular
cells (28). VEGF regulates multiple aspects of tumor angiogenesis through two high‑affinity receptor tyrosine kinases,
VEGFR1 (Flt‑1) and VEGFR2/KDR (Flk‑1), on endothelial
cells. The binding of VEGF and VEGFR results in endothelial
cell proliferation, migration, differentiation, tube formation and
upregulation of vascular permeability (29). Furthermore, VEGF
has been reported to be an indirect leukocyte migrating factor
through inducing the expression of MCP‑1 and IL‑8 (30,31). In
the present study, it was demonstrated that SU5416, a tyrosine
kinase inhibitor of VEGFR2, not only blocks tumor cell‑stimulated angiogenesis but also eliminates alcohol‑mediated
promotion of tumor angiogenesis (Fig. 3). Furthermore, SU5416
significantly inhibits alcohol‑stimulated mammary tumor
growth in mice. Therefore, this study confirms that VEGF has
an important role in alcohol promotion of mammary tumor
progression. Furthermore, it appears that the role of VEGF in
alcohol‑mediated tumor promotion is not tumor type‑specific. It
has been reported that moderate alcohol consumption increases
the expression of VEGF and angiogenesis in a mouse xenograft
model of melanoma (16). Multiple factors and signaling pathways may be responsible for alcohol promotion of mammary
tumor progression and VEGF signaling appears to be an important one. Future studies are required to elucidate the underlying
mechanisms whereby alcohol regulates the expression of VEGF.
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